Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcel A Beijk

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Journal of Interventional Cardiology|February 2, 2011
Twelve-month outcomes after coronary stenting with the Genous™ bio-engineered R Stent™ in diabetic patients from the e-HEALING registryPeter Damman, Margo Klomp, Marcel A Beijk, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 22, 2011
Clinical results after coronary stenting with the Genous™ Bio-engineered R stent™: 12-month outcomes of the e-HEALING (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth) worldwide registrySigmund Silber, Peter Damman, Margo Klomp, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|December 3, 2015
Procedural and clinical outcomes after use of the glycoprotein IIb/IIIa inhibitor abciximab for saphenous vein graft interventionsRalf E Harskamp, Niels Hoedemaker, L Kristin Newby, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|July 26, 2012
Clinical outcome after surgical or percutaneous revascularization in coronary bypass graft failureRalf E Harskamp, Marcel A Beijk, Peter Damman, et al.
International Journal of Cardiology|September 21, 2010
One-year clinical outcome after treatment of bare-metal stent in-stent restenosis with the paclitaxel-eluting stent in an unselected cohortMarcel A Beijk, Bimmer E Claessen, Karel T Koch, et al.
Coronary Artery Disease|April 11, 2012
Twelve-month clinical outcomes after coronary stenting with the Genous Bio-engineered R Stent in patients with a bifurcation lesion: from the e-HEALING (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth) registryMarcel A Beijk, Peter Damman, Margo Klomp, et al.
JACC. Cardiovascular Interventions|January 6, 2018
1-Year Clinical Performance of COMBO Stent Versus Xience Stent in All-Comers Patients With Coronary Artery DiseaseDeborah N Kalkman, Ruben Y G Tijssen, Robin P Kraak, et al.
JACC. Cardiovascular Interventions|October 6, 2018
1-Year Clinical Outcomes of All-Comer Patients Treated With the Dual-Therapy COMBO Stent: Primary Results of the COMBO CollaborationRobbert J de Winter, Jaya Chandrasekhar, Deborah N Kalkman, et al.
JACC. Cardiovascular Interventions|April 20, 2013
A systematic review and meta-analysis on primary percutaneous coronary intervention of an unprotected left main coronary artery culprit lesion in the setting of acute myocardial infarctionMarije M Vis, Marcel A Beijk, Maik J Grundeken, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 5, 2017
Five-year follow-up of the endothelial progenitor cell capturing stent versus the paxlitaxel-eluting stent in de novo coronary lesions with a high risk of coronary restenosisPier Woudstra, Deborah N Kalkman, Marcel A Beijk, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Journal of Interventional Cardiology|February 2, 2011
Twelve-month outcomes after coronary stenting with the Genous™ bio-engineered R Stent™ in diabetic patients from the e-HEALING registryPeter Damman, Margo Klomp, Marcel A Beijk, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 22, 2011
Clinical results after coronary stenting with the Genous™ Bio-engineered R stent™: 12-month outcomes of the e-HEALING (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth) worldwide registrySigmund Silber, Peter Damman, Margo Klomp, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|December 3, 2015
Procedural and clinical outcomes after use of the glycoprotein IIb/IIIa inhibitor abciximab for saphenous vein graft interventionsRalf E Harskamp, Niels Hoedemaker, L Kristin Newby, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|July 26, 2012
Clinical outcome after surgical or percutaneous revascularization in coronary bypass graft failureRalf E Harskamp, Marcel A Beijk, Peter Damman, et al.
International Journal of Cardiology|September 21, 2010
One-year clinical outcome after treatment of bare-metal stent in-stent restenosis with the paclitaxel-eluting stent in an unselected cohortMarcel A Beijk, Bimmer E Claessen, Karel T Koch, et al.
Coronary Artery Disease|April 11, 2012
Twelve-month clinical outcomes after coronary stenting with the Genous Bio-engineered R Stent in patients with a bifurcation lesion: from the e-HEALING (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth) registryMarcel A Beijk, Peter Damman, Margo Klomp, et al.
JACC. Cardiovascular Interventions|January 6, 2018
1-Year Clinical Performance of COMBO Stent Versus Xience Stent in All-Comers Patients With Coronary Artery DiseaseDeborah N Kalkman, Ruben Y G Tijssen, Robin P Kraak, et al.
JACC. Cardiovascular Interventions|October 6, 2018
1-Year Clinical Outcomes of All-Comer Patients Treated With the Dual-Therapy COMBO Stent: Primary Results of the COMBO CollaborationRobbert J de Winter, Jaya Chandrasekhar, Deborah N Kalkman, et al.
JACC. Cardiovascular Interventions|April 20, 2013
A systematic review and meta-analysis on primary percutaneous coronary intervention of an unprotected left main coronary artery culprit lesion in the setting of acute myocardial infarctionMarije M Vis, Marcel A Beijk, Maik J Grundeken, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 5, 2017
Five-year follow-up of the endothelial progenitor cell capturing stent versus the paxlitaxel-eluting stent in de novo coronary lesions with a high risk of coronary restenosisPier Woudstra, Deborah N Kalkman, Marcel A Beijk, et al.
Pageof 4